Root Financial Partners’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
Other funds holding FDMT
Root Financial Partners's FDMT Position: Q3 2026 in Review
Root Financial Partners opened a new position in 4D Molecular Therapeutics (FDMT) in Q3 2026: 23 shares worth $329. The stake represents ﹤0.01% of the portfolio and ranks #3372 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in FDMT as recently as Q1 2026.
Root Financial Partners first reported a position in FDMT in Q1 2026 and has held it in 2 quarters since. 167 funds tracked by Wall St. Rank hold FDMT as of Q3 2026.
- Root Financial Partners held 23 shares of 4D Molecular Therapeutics worth $329 as of Q3 2026.
- 4D Molecular Therapeutics was a new Root Financial Partners position in Q3 2026.
- 4D Molecular Therapeutics made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3372 holding.
- Root Financial Partners first reported a position in 4D Molecular Therapeutics in Q1 2026 and has held it in 2 quarters since.
- 167 funds tracked by Wall St. Rank held 4D Molecular Therapeutics as of Q3 2026.
Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.